The 60th Annual ASH meeting & exposition was held was held December 1-4, 2018 in San Diego, CA. The following are the posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

Manit Munshi, Cristina Jimenez, Amanda Kofides, Guang Yang, Zach Hunter

Click on the poster to download a full size PDF version. For more information about ASH-2018, please visit http://www.hematology.org/Annual-Meeting/

Comprehensive Integration of Whole Genome, Transcriptome and Methylation Profiling Reveals Novel Gene Dysregulation Including IL15, SOCS6 and CARD11 Associated with MYD88 and CXCR4 Genotype Status in WM

Zachary R Hunter, Gloria G Chan, Cristina Jimenez, Nickolas Tsakmaklis, Lian Xu, Jiaji G Chen, Maria Demos, Amanda Kofides, Manit Munshi, Maria Luisa Guerrera, Xia Liu2, Guang Yang, Jorge J. Castillo, Ari M Melnick and Steven P Treon

Genomic Analysis of Ibrutinib Resistance in Waldenström’s Macroglobulinemia

Cristina Jiménez, PhD, Gloria G Chan, MS, Lian Xu, MS, Nickolas Tsakmaklis, JiajiG Chen, Maria Demos, Amanda Kofides, Maria Luisa Guerrera, MD, Xia Liu, MD, ManitMunshi, MS, Joshua Gustine, MPH, Guang Yang, PhD, Jorge J. Castillo, MD, Steven P Treon, MD, PhD, FRCP and Zachary R Hunter, PhD

Ibrutinib for the Treatment of Bing-Neel Syndrome

Gilad Itchaki, MD, Jonas Paludo, MD, Maria Lia Palomba, MD, Marzia Varettoni, MD, Dipti Talaulikar, PhD, FRACP, Julio C Chavez, MD, Christian Buske, MD, Alessandra Tedeschi, MD, David Simpson, MBChB, FRACP, Constantine S Tam, MBBS, MD, FRACP, Samar Issa, FRACP, Stephen M Ansell, MD, PhD, Steven P Treon, MD, PhD, FRCP and Jorge J Castillo, MD

Deepening of response after completing rituximab-containing primary therapy in patients with Waldenstrom's Macroglobulinemia

Jorge J. Castillo, Andrew Keezer, Kirsten Meid, Toni E. Dubeau, Lian Xu, Zachary R. Hunter, Guang Yang, Stephen P. Treon

Ibrutinib dose reduction does not affect progression-free survival in patients with Waldenström macroglobulinemia

Jorge J. Castillo, Andrew Keezer, Kirsten Meid, Toni E. Dubeau, Lian Xu, Zachary R. Hunter, Guang Yang, Steven P Treon

Non-IgM Secreting Lymphoplasmacytic Lymphoma - Experience of a Reference Center for Waldenstrom's Macroglobulinemia

Glad Itchaki, MD, Toni Dubeau, NP, ANdrew Keezer, BS, Kirsten Meid, MPH, Lian Xu, MS, Guang Yang, PhD, Zachary Hunter, PhD, Steven P. Treon, MD, PhD, FRCP and Jorge J. Castillo, MD

Phase II Study of Venetoclax in Previously Treated Waldenstrom's Macroglobulinemia

Castillo JJ, Allan JN, Siddiqi T, Advani RH, Gustine J, Keezer A, Meid K, Dubeau TE, Hunter ZR, Yang G, Furman RR, Davids MS, Treon SP

Alternative Mutations and Isoform Dysregulation in MYD88 in Waldenstrom’s Macroglobulinemia

Amanda Kofides, Maria Demos, Nickolas Tsakmaklis, Lian Xu, MS, Xia Liu, MD, Guang Yang, PhD, Jiaji G Chen, Manit Munshi, MS, Joshua Gustine, MPH, Christopher Patterson, Maria Luisa Guerrera, MD, Gloria G. Chan, MS, Cristina Jimenez, PhD, Jorge J. Castillo, MD, Steven P Treon, MD, PhD, FRCP and Zachary R Hunter, PhD

Mutated MYD88 Cross-talk to BCR Signaling through Activating SYK in Waldenstrom's Macroglobulinemia

Manit Munshi, Xia Liu, Jiaji Chen, Lian Xu, Nickolas Tsakmaklis, Maria Demos, Amanda Kofides, Gloria Chan, Zachary Hunter, Maria Louisa Guerrera, Cristina Jimenez, Christopher J. Patterson, Kirsten Meid, Joshua Gustine, Andrew Keezer, Patricia Severns, Toni Dubeau, Jorge J. Castillo, Steven P. Treon and Guang Yang